| CARA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CARA shares outstanding history going back to 1/31/2014:
Also see: CARA Market Cap History CARA YTD Return |
CARA Shares Outstanding History — Cara Therapeutics Share Count Over Time
As of 3/6/2025 Cara Therapeutics has 4.57 million CARA shares outstanding. Investors often track the CARA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CARA share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 1/31/2014.
| CARA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARA Historical Shares Outstanding: +8.65% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CARA Stock Price Chart |
| About Tvardi Therapeutics Inc |
| Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. Co. is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. We show 45 historical shares outstanding datapoints in our coverage of CARA's shares outstanding history. Understanding the changing numbers of CARA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CARA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CARA by allowing them to research CARA shares outstanding history as well as any other stock in our coverage universe. |
| CARA Current Stock Quote |
Quotes delayed 20 minutes  Free CARA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CARA Share Performance |
| Shares Outstanding Peers |
| Cara Therapeutics (CARA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CARM Shares Outstanding History CASI Shares Outstanding History CASM Shares Outstanding History CATB Shares Outstanding History CATS Shares Outstanding History CBAY Shares Outstanding History CBIO Shares Outstanding History CBLI Shares Outstanding History CBM Shares Outstanding History CBMG Shares Outstanding History More Healthcare companies » |
CARA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
